Firebrick Pharma Ltd (FRE) — Financial Flexibility Index
Firebrick Pharma Ltd (FRE) has a Financial Flexibility Index of -3.08x as of December 2025. Free cash flow of AU$-1.05 Million (operating CF AU$-1.05 Million minus capex AU$3.00) represents -3% of total liabilities (AU$341.73K). Check FRE PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Firebrick Pharma Ltd Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for Firebrick Pharma Ltd across 7 annual periods. See Firebrick Pharma Ltd current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Firebrick Pharma Ltd (2019–2025)
Year-by-year free cash flow to debt coverage for Firebrick Pharma Ltd. For the full company profile including market capitalisation, see FRE company net worth.
| Year | Flexibility Index | Free Cash Flow (AUD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -6.25x | AU$-1.70 Million | AU$-1.78 Million | AU$271.28K | ▲ +22.4% |
| 2024 | -8.06x | AU$-2.34 Million | AU$-2.34 Million | AU$291.07K | ▲ +29.4% |
| 2023 | -11.42x | AU$-5.78 Million | AU$-5.78 Million | AU$506.44K | ▼ -23.2% |
| 2022 | -9.26x | AU$-4.17 Million | AU$-4.20 Million | AU$450.10K | ▼ -3.6% |
| 2021 | -8.94x | AU$-1.92 Million | AU$-1.94 Million | AU$214.80K | ▼ -143.7% |
| 2020 | -3.67x | AU$-968.94K | AU$-985.01K | AU$264.22K | ▲ +66.4% |
| 2019 | -10.91x | AU$-1.06 Million | AU$-1.06 Million | AU$97.61K | — |